ArticlePoultry science2025
Antimicrobial resistance patterns of Campylobacter jejuni isolated from retail raw chicken meat in Jordan.
Article in Poultry science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Antimicrobial resistance in poultry meat in the mediterranean region: prevalence, public health implications, and control strategies: A review.Poultry science · 2026Review
- Phenotypic and PCR-based analysis of antimicrobial resistance in heat-treated multidrug-resistant Salmonella spp. and Campylobacter jejuni isolated from raw chicken meat.Poultry science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Campylobacteriosis is among the most common infectious foodborne diseases caused by the bacterium Campylobacter jejuni. The objective of this study was to investigate the prevalence rate, antimicrobial resistance (AMR) profiles, and the presence of targeted AMR genes among C. jejuni isolated from chilled raw chicken meat at different retail markets and abattoirs in Jordan. Seven hundred raw chicken samples (200 eviscerated carcasses from abattoirs, 400 eviscerated carcasses from retail markets, and 100 chicken breasts from retail markets) were collected between October 2022 and August 2024. Campylobacter spp. were detected in 23.6 % (165/700) of samples, with 16.9 % (118/700) confirmed as C. jejuni via hipO-specific gene using PCR procedure. Carcasses from the retail market showed the highest prevalence rate of C. jejuni (19.5 %), followed by abattoirs (16.5 %) and retail chicken breasts (7.0 %). Antimicrobial susceptibility testing (AST) revealed alarming resistance rates: β-lactams (ampicillin: 50.8 %, ceftazidime: 84.7 %); tetracycline (69.5 %); and ciprofloxacin (72.9 %). Multidrug resistance (MDR) was observed in 36.4 % (43/118) of isolates. PCR identified key resistance genes: bla
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.